Talk:Plerixafor

Pharmacology C‑class Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
C	This article has been given a rating which conflicts with the project-independent quality rating in the banner shell. Please resolve this conflict if possible.
Mid	This article has been rated as Mid-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Chemicals Low‑importance

	This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals articles
Low	This article has been rated as Low-importance on the project's importance scale.

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Plerixafor.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Cancer inhibitor

Should I say "small molecule cancer therapy?" —Preceding unsigned comment added by 165.123.243.168 (talk) 02:13, 13 December 2007 (UTC)[reply]

Move

I propose this page be moved to plerixafor in accordance with WikiProject Pharmacology Naming conventions, as plerixafor is the recommended International Nonproprietary Name: [1].

If there is no objection, I will perform the move in 24 hours. Fvasconcellos 18:40, 24 March 2007 (UTC)[reply]

I have no objection. --Arcadian 19:45, 24 March 2007 (UTC)[reply]

Well, if the article creator doesn't object... :) I'll wait until tomorrow anyway, pro forma. Fvasconcellos 22:50, 24 March 2007 (UTC)[reply]

Move done. Fvasconcellos 02:49, 26 March 2007 (UTC)[reply]

How much forms zinc complexes

What % in circulation is singly or doubly complexed with zinc ? (Do typical dosages remove much zinc from patient ? - Why not administer as the zinc complex ? ) - Rod57 (talk) 11:27, 27 October 2015 (UTC)[reply]

Research - use with chemo

Aug 2015 Cancer Research : Tested in mice to suppress tumour metastasis caused by some chemo regimens.^{[citation needed]} - Rod57 (talk) 11:27, 27 October 2015 (UTC)[reply]